Xeris Biopharma Holdings, Inc. XERS Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Xeris Biopharma Holdings, Inc.’s reported figures.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s invested capital?
- Xeris Biopharma Holdings, Inc. (XERS) reported invested capital of $159.81M in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s invested capital changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s invested capital decreased by 8.8% year-over-year, from $175.18M to $159.81M.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s invested capital?
- Over 5 years (2020 to 2025), Xeris Biopharma Holdings, Inc.'s invested capital has grown at a 14.1% compound annual growth rate (CAGR), from $83.18M to $160.75M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).